29 November 2024 : Clinical Research
Effects of Nutritional Protocol Changes on Hemodialysis Adequacy and Patient Health During the COVID-19 Pandemic
Cebrail KaracaDOI: 10.12659/MSM.946471
Med Sci Monit 2024; 30:e946471
Table 1 Baseline demographic and clinical features of all patients.
| Features | Findings |
|---|---|
| Male sex, n (%) | 44 (58) |
| Age (years), mean±SD | 58.9±15.6 |
| Body mass index (kg/m), median (IQR) | 24 (20.6–27) |
| Etiology of chronic kidney disease, n (%) | |
| Diabetes mellitus | 32 (42.1) |
| Hypertension | 12 (15.8) |
| Urologic causes | 9 (11.8) |
| Chronic glomerulonephritis | 3 (3.9) |
| Polycystic kidney disease | 1 (1.3) |
| Other | 1 (1.3) |
| Unknown | 18 (23.8) |
| Hypertension, n (%) | 43 (56.6) |
| Diabetes mellitus, n (%) | 32 (42.1) |
| Coronary heart disease, n (%) | 16 (21) |
| Dyslipidemia, n (%) | 5 (6.6) |
| Congestive heart disease, n (%) | 1 (1.3) |
| Hemodialysis duration (months), median (IQR) | 85 (60–142.8) |
| IQR – interquartile range; SD – standard deviation. | |






